Literature DB >> 20074693

Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice.

Dong Zhang1, Mohamed Al-Hendy, Gloria Richard-Davis, Valerie Montgomery-Rice, Chakradhari Sharan, Veera Rajaratnam, Anjali Khurana, Ayman Al-Hendy.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the effect of epigallocatechin gallate (EGCG) on rat leiomyoma (ELT3) cells in vitro and in a nude mice model. STUDY
DESIGN: ELT3 cells were treated with various concentrations of EGCG. Cell proliferation, proliferation cell nuclear antigen (PCNA), and cyclin-dependent kinase 4 (Cdk4) protein levels were evaluated. ELT3 cells were inoculated subcutaneously in female athymic nude mice. Animals were fed 1.25 mg EGCG (in drinking water)/mouse/day. Tumors were collected and evaluated at 4 and 8 weeks after the treatment.
RESULTS: Inhibitory effect of EGCG (200 micromol/L) on ELT3 cells was observed after 24 hours of treatment (P < .05). At > or = 50 micromol/L, EGCG significantly decreased PCNA and Cdk4 protein levels (P < .05). In vivo, EGCG treatment dramatically reduced the volume and weight of tumors at 4 and 8 weeks after the treatment (P < .05). The PCNA and Cdk4 protein levels were significantly reduced in the EGCG-treated group (P < .05).
CONCLUSION: EGCG effectively inhibits proliferation and induces apoptosis in rat ELT3 uterine leiomyoma cells in vitro and in vivo. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20074693      PMCID: PMC2834812          DOI: 10.1016/j.ajog.2009.10.885

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  44 in total

1.  Dose-dependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues.

Authors:  Joshua D Lambert; Mao-Jung Lee; Lauren Diamond; Jihyeung Ju; Jungil Hong; Mousumi Bose; Harold L Newmark; Chung S Yang
Journal:  Drug Metab Dispos       Date:  2005-10-04       Impact factor: 3.922

Review 2.  Molecular targets of dietary agents for prevention and therapy of cancer.

Authors:  Bharat B Aggarwal; Shishir Shishodia
Journal:  Biochem Pharmacol       Date:  2006-02-23       Impact factor: 5.858

3.  Green tea consumption and the risk of pancreatic and colorectal cancers.

Authors:  B T Ji; W H Chow; A W Hsing; J K McLaughlin; Q Dai; Y T Gao; W J Blot; J F Fraumeni
Journal:  Int J Cancer       Date:  1997-01-27       Impact factor: 7.396

4.  Hormonal regulation of catechol-O-methyl transferase activity in women with uterine leiomyomas.

Authors:  Salama A Salama; Shu-Leong Ho; Hui-Qun Wang; Jukka Tenhunen; Carola Tilgmann; Ayman Al-Hendy
Journal:  Fertil Steril       Date:  2006-05-26       Impact factor: 7.329

5.  Green tea composition, consumption, and polyphenol chemistry.

Authors:  H N Graham
Journal:  Prev Med       Date:  1992-05       Impact factor: 4.018

Review 6.  Gene therapy and uterine leiomyoma: a review.

Authors:  Ayman Al-Hendy; Salama Salama
Journal:  Hum Reprod Update       Date:  2006-04-07       Impact factor: 15.610

7.  Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups.

Authors:  Ayman Al-Hendy; Salama A Salama
Journal:  J Soc Gynecol Investig       Date:  2006-02

8.  Estrogen metabolite 2-methoxyestradiol induces apoptosis and inhibits cell proliferation and collagen production in rat and human leiomyoma cells: a potential medicinal treatment for uterine fibroids.

Authors:  Salama A Salama; Abdelhakim Ben Nasr; Raghvendra K Dubey; Ayman Al-Hendy
Journal:  J Soc Gynecol Investig       Date:  2006-11-07

9.  Reduced risk of esophageal cancer associated with green tea consumption.

Authors:  Y T Gao; J K McLaughlin; W J Blot; B T Ji; Q Dai; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1994-06-01       Impact factor: 13.506

Review 10.  Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.

Authors:  Naghma Khan; Farrukh Afaq; Mohammad Saleem; Nihal Ahmad; Hasan Mukhtar
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

View more
  28 in total

1.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

Review 2.  Medical treatment of uterine leiomyoma.

Authors:  Mohamed Sabry; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2012-02-28       Impact factor: 3.060

3.  Matrix production and remodeling as therapeutic targets for uterine leiomyoma.

Authors:  Caitlin Fujisawa; John J Castellot
Journal:  J Cell Commun Signal       Date:  2014-07-11       Impact factor: 5.782

4.  Paricalcitol, a vitamin d receptor activator, inhibits tumor formation in a murine model of uterine fibroids.

Authors:  Sunil K Halder; Chakradhari Sharan; Omar Al-Hendy; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2014-06-12       Impact factor: 3.060

Review 5.  Therapeutic targeting of cellular metabolism in cells with hyperactive mTORC1: a paradigm shift.

Authors:  Doug Medvetz; Carmen Priolo; Elizabeth P Henske
Journal:  Mol Cancer Res       Date:  2014-10-08       Impact factor: 5.852

Review 6.  Uterine leiomyomas: individualizing the approach to a heterogeneous condition.

Authors:  Shannon K Laughlin; Elizabeth A Stewart
Journal:  Obstet Gynecol       Date:  2011-02       Impact factor: 7.661

Review 7.  A Review of Integrative Medicine in Gynaecological Oncology.

Authors:  M Kalder; T Müller; D Fischer; A Müller; W Bader; M W Beckmann; C Brucker; C C Hack; V Hanf; A Hasenburg; A Hein; S Jud; M Kiechle; E Klein; D Paepke; A Rotmann; F Schütz; G Dobos; P Voiß; S Kümmel
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-02       Impact factor: 2.915

8.  Targeted Adenoviral Vector Demonstrates Enhanced Efficacy for In Vivo Gene Therapy of Uterine Leiomyoma.

Authors:  Mohamed Abdelaziz; Lotfy Sherif; Mostafa ElKhiary; Sanjeeta Nair; Shahinaz Shalaby; Sara Mohamed; Noura Eziba; Mohamed El-Lakany; David Curiel; Nahed Ismail; Michael P Diamond; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2016-02-16       Impact factor: 3.060

9.  The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4.

Authors:  Alfred Csibi; Sarah-Maria Fendt; Chenggang Li; George Poulogiannis; Andrew Y Choo; Douglas J Chapski; Seung Min Jeong; Jamie M Dempsey; Andrey Parkhitko; Tasha Morrison; Elizabeth P Henske; Marcia C Haigis; Lewis C Cantley; Gregory Stephanopoulos; Jane Yu; John Blenis
Journal:  Cell       Date:  2013-05-09       Impact factor: 41.582

10.  Anti-Uterine Fibroid Effect of Standardized Labisia Pumila Var. Alata Extracts In Vitro and in Human Uterine Fibroid Cancer Xenograft Model.

Authors:  Norfahana Zakaria; Khamsah Suryati Mohd; Mohammed Ali Ahmed Saeed; Loiy Elsir Ahmed Hassan; Armaghan Shafaei; Fouad Saleih R Al-Suede; Abdul Hakeem Memon; Zhari Ismail
Journal:  Asian Pac J Cancer Prev       Date:  2020-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.